NIOX Group (NIOX) Competitors

NIOX Group (LON:NIOX) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Do analysts rate NIOX or EKF?

NIOX Group currently has a consensus price target of GBX 90, suggesting a potential upside of 20.64%. Given NIOX Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe NIOX Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is NIOX or EKF more profitable?

NIOX Group has a net margin of 28.21% compared to EKF Diagnostics' net margin of 9.37%. NIOX Group's return on equity of 13.29% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	28.21%	13.29%	3.95%
EKF Diagnostics	9.37%	7.03%	5.27%

Do insiders & institutionals have more ownership in NIOX or EKF?

7.6% of NIOX Group shares are held by institutional investors. Comparatively, 50.0% of EKF Diagnostics shares are held by institutional investors. 4.9% of NIOX Group shares are held by insiders. Comparatively, 39.4% of EKF Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has more volatility & risk, NIOX or EKF?

NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.

Which has better earnings & valuation, NIOX or EKF?

NIOX Group has higher earnings, but lower revenue than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£46M	6.78	£995.88M	£0.01	5,968.00
EKF Diagnostics	£50.22M	2.58	£4.68M	£0.01	2,133.33

Does the media prefer NIOX or EKF?

In the previous week, EKF Diagnostics had 1 more articles in the media than NIOX Group. MarketBeat recorded 1 mentions for EKF Diagnostics and 0 mentions for NIOX Group. NIOX Group's average media sentiment score of 0.00 beat EKF Diagnostics' score of -0.64 indicating that NIOX Group is being referred to more favorably in the media.

Company	Overall Sentiment
NIOX Group	Neutral
EKF Diagnostics	Negative

Summary

NIOX Group beats EKF Diagnostics on 10 of the 16 factors compared between the two stocks.